Literature DB >> 8959748

Relaxation of human temporal artery by endothelin ETB receptors.

G A Lucas1, L R White, R Juul, J Cappelen, J Aasly, L Edvinsson.   

Abstract

Endothelin receptors have been characterized in human temporal artery by molecular biological methods and in vitro pharmacology. Reverse transcriptase-polymerase chain reaction was used to detect mRNA encoding ETA and ETB receptors in normal and endothelium-denuded arteries. Vasomotor response experiments with a specific ETA antagonist (FR 139317) suggested the presence of ETA subtypes. Marked ETB-mediated relaxation was obtained with ET-3 when ETA activity was blocked in precontracted arteries. Relaxation was significantly reduced by bosentan, indomethacin, and a nitric oxide synthase inhibitor. It may be speculated that the relaxant activity is mediated through ETB1 receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8959748     DOI: 10.1016/s0196-9781(96)00177-5

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

Review 1.  Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

2.  Neuroprotective Effect of IRL-1620, an Endothelin B Receptor Agonist, on a Pediatric Rat Model of Middle Cerebral Artery Occlusion.

Authors:  Enrique G Cifuentes; Mary G Hornick; Suresh Havalad; Ramona L Donovan; Anil Gulati
Journal:  Front Pediatr       Date:  2018-10-23       Impact factor: 3.418

Review 3.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.